Skip to main content

Copyright

When an author submits a manuscript for publishing they will need to sign a license agreement with Springer Nature to allow us to publish their article. According to this agreement: 

  • authors of articles published in Molecular Brain retain the copyright of their articles. 
  • authors grant Springer Nature a license to publish the article and identify itself as the original publisher. 
  •  authors will retain broad re-use rights to their article content for their future publications. -
  • when Springer Nature publishes the article we will apply a Creative Commons licence allowing re-use of the article by third parties for particular purposes. 

Molecular Brain articles are published open access under a CC BY licence (Creative Commons Attribution 4.0 International licence). CC BY articles may be shared and adapted for any purpose, including commercially, so long as the authors are credited. 

This journal also follows a CC0 data policy. The Creative Commons CC0 1.0 Public Domain Dedication waiver will apply to all published data in this journal. 

You may also wish to find out about licence variations available to meet funder and institutional OA licence requirements. Learn more in our guide to licensing, copyright and author rights for journal articles.

Affiliated with

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 3.3
    5-year Journal Impact Factor: 3.8
    Source Normalized Impact per Paper (SNIP): 0.844
    SCImago Journal Rank (SJR): 1.315

    Speed 2024
    Submission to first editorial decision (median days): 15
    Submission to acceptance (median days): 88

    Usage 2024
    Downloads: 993,076
    Altmetric mentions: 429

Molecular Brain is a member of the Neuroscience Peer Review Consortium.

New Content Item (1)
Molecular Brain has partnered with Publons to give you official recognition for your contribution to peer review. Create a free profile to have your reviews automatically added.